Nurix Therapeutics Inc. (NRIX)
NASDAQ · Healthcare
Nurix Therapeutics Inc. Revenue 2019–2025
Nurix Therapeutics Inc. annual/quarterly revenue history and growth rate from 2019 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Nurix Therapeutics Inc. revenue for the quarter ending February 28, 2026 was 6.3 M, a 66.12% decrease year-over-year.
- Nurix Therapeutics Inc. revenue for the twelve months ending February 28, 2026 was 76.7 M, a 28.33% increase year-over-year.
- Nurix Therapeutics Inc. annual revenue for 2025 was 84.0 M, a 53.95% increase from 2024.
- Nurix Therapeutics Inc. annual revenue for 2024 was 54.5 M, a 29.15% decrease from 2023.
- Nurix Therapeutics Inc. annual revenue for 2023 was 77.0 M, a 99.31% increase from 2022.
- Nurix Therapeutics Inc. annual revenue for 2022 was 38.6 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Nurix Therapeutics Inc. Revenue — FAQ
Nurix Therapeutics Inc. (NRIX) revenue over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
What is Nurix Therapeutics Inc.'s revenue?
Nurix Therapeutics Inc. (NRIX) reported revenue of $84M for fiscal 2025.
Where can I see NRIX's revenue history?
The chart and table above show Nurix Therapeutics Inc.'s revenue by year and by quarter, including the growth rate.